Back to Results

A Prospective Study Evaluating Seroprevalence and Seroconversion of Antibodies Against Adeno-associated Virus (AAV)

Interested in this Trial?

Contact Us

Trial Status Terminated

Trial Identifier

NCT05580692

Condition

Hemophilia A, Hemophilia a

The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.

Trial Summary

A prospective cohort study utilizing biospecimen sample collection from adult Hemophilia A subjects to evaluate and characterize seroprevalence and the seroconversion of antibodies against AAV serotypes

Eligibility Criteria

Birth Sex

All

Age

From 18 Years

Healthy Volunteers

No

Drug/Treatment:

Biospecimen Collection

Phase:

Na

Study Type:

Interventional

Number of Participants:

321

Study Started:

2023-03-14

Study Updated:

2024-08-19

Trial Locations

  • Instituto Hematologia Arbesu

    Godoy Cruz, Mendoza Province, Argentina

  • Hospital Ramon Jose Vidal

    Corrientes, Argentina

  • Medico Hematologo

    Mendoza, Argentina

  • Instituto de Hematologia y Medicina Clinica Dr. RUben Davoli

    Rosario, Argentina

  • Royal Prince Alfred Hospital

    Camperdown, Australia

  • Haemophilia and Haemostasis Centre Level 1 Cancer Centre South Metropolitan Health Service Fiona Stanley Hospital

    Murdoch, Australia

  • Medical University of Vienna

    Vienna, Austria

  • King Faisal Specialist Hospital & Research Center

    Riyadh, Saudi Arabia

  • King Saud University Medical City King Saud University

    Riyadh, Saudi Arabia

  • Skane University Hospital

    Malmo, Sweden

  • ME Centrum för kliniska cancerstudier - House H3

    Solna, Sweden

  • Acibadem Adana Hospital

    Adana, Turkey (Türkiye)

  • Hacettepe University

    Ankara, Turkey (Türkiye)

  • Gaziantep University Medical Faculty Sahinbey Educational Research Hospital

    Gaziantep, Turkey (Türkiye)

  • Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty

    Istanbul, Turkey (Türkiye)

  • Ege University Medical Faculty

    Izmir, Turkey (Türkiye)

  • Ondokuz Mayis Univ. Med. Fac.

    Samsun, Turkey (Türkiye)

  • Sheikh Shakhbout Medical City

    Abu Dhabi, United Arab Emirates

Inclusion Criteria

  • Adult Subjects with Hemophilia A

Exclusion Criteria

  • Subject previously treated with AAV vector gene therapy

Contact BioMarin Clinical Trials

Please complete and submit the following form to express interest in participating and request more information about one of our active clinical trials

*required fields

"*" indicates required fields

Please select the trial that you are interested in from the dropdown below. Note that this list only includes currently active trials. If you cannot find the trial you are seeking, please enter the study identifier and title in the comments box below, along with any other details you would like us to know to help address your inquiry.
Consent*
Consent*
For more Information about BioMarin's privacy obligations or to exercise your privacy rights, please visit BioMarin's Data Privacy Center.
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

What’s Next?

Visit the following links to learn more about clinical trials.

Discuss this trial with your care team.

You may wish to print this page to share the details with your healthcare providers and discuss whether you may be eligible.

Print

Get in touch.

Contact Us